Homepage
Medication Guide
How effective is Canakinumab (ILARIS) in treatment?
Canakinumab is an interleukin-1β (IL-1β) blocker used for diseases such as cryopyrin-associated periodic syndromes (CAPS), hyperimmunoglobulin D syndrome (HIDS), mevalonate kinase deficiency (MKD), an...
513
Friday, August 8th, 2025, 16:23
Dosage and Administration of Canakinumab (ILARIS)
As an innovative biotherapeutic drug, canakinumab (ILARIS) is widely used in the treatment of various inflammatory diseases, including periodic fever syndromes (CAPS), hyperimmunoglobulin D syndrome/m...
513
Friday, August 8th, 2025, 16:13
Eligible Populations for Canakinumab (ILARIS)
Canakinumab (ILARIS) is an innovative biotherapeutic drug that is playing an increasingly important role in the medical field. It is mainly used to treat a variety of inflammatory diseases, bringing n...
506
Friday, August 8th, 2025, 16:05
Canakinumab: Instructions, Medical Insurance, Price, Efficacy, and Side Effects
Canakinumab, mainly used for the treatment of various autoinflammatory diseases and gout, is an innovative biological agent whose unique efficacy has been widely recognized by the international medica...
509
Friday, August 8th, 2025, 16:00
How to buy canakinumab?
Canakinumab, also known as canakinumab, Ilaris. Developed by Novartis of Switzerland, it is an effective therapeutic drug for various autoinflammatory diseases and gout. Its purchasing channels, price...
504
Friday, August 8th, 2025, 15:52
What is the latest price of canakinumab in 2025?
Canakinumab is an effective therapeutic drug for various autoimmune diseases, Still's disease, and gout. Its price, purchasing channels, and storage methods have always been the focus of patients&...
508
Friday, August 8th, 2025, 15:48
Who is the manufacturer of Fyarro(Nab-Sirolimus) albumin?
Sirolimus albumin is a doxetine drug that works by inhibiting the growth and division of cancer cells. Studies have found that the drug has a higher concentration in tumor tissue, which means that mor...
505
Monday, July 28th, 2025, 17:44
Precautions for Fyarro(sirolimus) Albumin (Fyarro)?
Fyarro(sirolimus) albumin, which was approved by the US Food and Drug Administration in November 2021, can be used to treat malignant perivascular epithelioid cell tumors. As an mTOR inhibitor, w...
507
Monday, July 28th, 2025, 17:36
How to use Fyarro(sirolimus) albumin
Fyarro(sirolimus) albumin has shown significant effectiveness in the treatment of malignant perivascular epithelioid cell tumors, not only improving the survival rate of patients, but also having...
511
Monday, July 28th, 2025, 17:10
Diseases that may be caused by the use of Fyarro(sirolimus) albumin
Fyarro(sirolimus) albumin (Fyarro) is a drug developed by Edison Pharmaceuticals (AADI) in the United States. The following mainly explains the diseases that may be caused by the use of Fyarro(si...
506
Monday, July 28th, 2025, 16:54
160 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved